VitaCholine (Choline bitartrate)

VitaCholine is a branded form of choline bitartrate, a salt of choline and tartaric acid that delivers bioavailable choline to the body. Its primary mechanism involves serving as a precursor to the neurotransmitter acetylcholine and as a structural component of phosphatidylcholine in cell membranes.

Origin & History

VitaCholine is a branded form of choline bitartrate, a synthetic organic compound with the chemical formula C₉H₁₉NO₇ that appears as a white crystalline powder. It is produced chemically by reacting trimethylamine with ethylene oxide and water, followed by tartaric acid, and has no natural plant or organism source.

Historical & Cultural Context

Choline bitartrate has no documented historical or traditional medicine use, being a modern synthetic compound without roots in traditional systems like Ayurveda or TCM. While choline itself occurs naturally in foods like liver and eggs, the bitartrate salt form lacks any traditional context.

Health Benefits

• May support acetylcholine production for neurological function (evidence quality: theoretical, no clinical trials cited)
• Potentially provides choline for phospholipid synthesis in cell membranes (evidence quality: mechanistic understanding only)
• Could serve as a methyl donor for methylation pathways when methionine/folate are limited (evidence quality: biochemical principle, no human studies)
• Used in infant formulas and fortified foods for choline delivery (evidence quality: regulatory approval for use)
• Water-soluble form may offer rapid choline availability versus bound forms (evidence quality: physicochemical property, no comparative studies)

How It Works

Choline bitartrate dissociates in the gut to release free choline, which is taken up by neurons and converted to acetylcholine via choline acetyltransferase (ChAT) using acetyl-CoA as the acetyl donor. Choline is also phosphorylated to phosphocholine and incorporated into phosphatidylcholine via the CDP-choline (Kennedy) pathway, supporting cell membrane structure and signaling. Additionally, choline is oxidized to betaine, which donates methyl groups through the betaine-homocysteine methyltransferase (BHMT) reaction, contributing to one-carbon metabolism and homocysteine regulation.

Scientific Research

The research dossier reveals a complete absence of specific human clinical trials, RCTs, or meta-analyses on choline bitartrate or VitaCholine, with no PubMed PMIDs available. While general references note its theoretical use in supporting acetylcholine production, no study designs, sample sizes, or clinical outcomes are documented.

Clinical Summary

Human evidence specifically for choline bitartrate as a standalone cognitive supplement is limited, with most mechanistic data extrapolated from broader choline research. Observational studies, including analyses from the Framingham Heart Study cohort, associate higher dietary choline intake with better cognitive performance scores, though causality is not established. Randomized controlled trials on choline supplementation for cognitive outcomes generally use citicoline or alpha-GPC rather than choline bitartrate, making direct efficacy comparisons difficult. The strongest clinical evidence for choline relates to preventing deficiency-associated liver steatosis and neural tube defects, where adequate intake is well-established by the Institute of Medicine.

Nutritional Profile

VitaCholine (choline bitartrate) is a salt form of choline combined with tartaric acid, yielding approximately 41% elemental choline by weight (e.g., 500mg choline bitartrate provides ~205mg elemental choline). Choline is an essential nutrient classified under the B-vitamin family. Key nutritional characteristics: Adequate Intake (AI) for choline is 425mg/day (women) and 550mg/day (men) per Institute of Medicine guidelines. As a water-soluble compound, choline bitartrate dissolves readily in aqueous environments. Bioavailability of choline from bitartrate salt is considered moderate to good; absorption occurs primarily in the small intestine via active transport (CTL1, CTL2 transporters) and passive diffusion at higher concentrations. Comparative bioavailability studies suggest choline bitartrate is absorbed less efficiently than phosphatidylcholine (~10% lower) but more predictably than dietary choline from whole foods due to standardized dosing. The tartrate moiety contributes negligible caloric value (~4 kcal/g carbohydrate equivalent in trace amounts). No significant macronutrient content (proteins, fats, complex carbohydrates). Micronutrient contribution is limited to choline itself; no meaningful vitamins or minerals supplied. Bioactive compounds: choline serves as precursor to acetylcholine (neurotransmitter), phosphatidylcholine and sphingomyelin (structural phospholipids), and betaine (methyl donor via oxidation pathway). Plasma choline levels typically rise within 1–2 hours post-ingestion. VitaCholine is a trademarked form (Balchem Corporation) standardized for purity; no evidence of superior bioavailability versus generic choline bitartrate.

Preparation & Dosage

No clinically studied dosage ranges for choline bitartrate have been established in the available research. The compound is used in supplements, infant formulas, and fortified foods, but specific doses remain unquantified in clinical settings. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Phosphatidylserine, DHA omega-3, B-complex vitamins, Alpha-GPC, Huperzine A

Safety & Interactions

Choline bitartrate is generally recognized as safe at doses up to 3.5 g per day, the Tolerable Upper Intake Level (UL) set by the National Academies; doses above this threshold may cause fishy body odor, nausea, vomiting, excessive sweating, and hypotension. High choline intake may increase trimethylamine N-oxide (TMAO) production via gut microbial metabolism, which some cardiovascular research associates with elevated atherosclerosis risk, though this relationship remains mechanistically debated. Choline may interact with anticholinergic medications such as scopolamine or diphenhydramine by opposing their receptor-blocking effects, potentially reducing drug efficacy. Choline is considered safe during pregnancy at the Adequate Intake level of 450 mg per day and is essential for fetal brain development, though supplementation beyond the UL during pregnancy is not well-studied.